Screener
Briacell Therapeutics Corp. BCTX Q1 2026 earnings
Reported March 10, 2026 · After market close
EPS-$2.58Beat by $2.26
EPS estimate-$4.84
Next report
Date not yet announcedVersus estimates
Diluted EPS
Q3 2026-$1.24Q2 2026-$0.99
Q1 2026-$2.58Beat by $2.26
Q4 2025-$4.35Q3 2025-$10.49Beat by $1.62Q2 2025-$16.40Beat by $1.20FAQ
- When did Briacell Therapeutics Corp. report Q1 2026 earnings?
- Briacell Therapeutics Corp. (BCTX) reported Q1 2026 earnings on March 10, 2026 after market close.
- What were Briacell Therapeutics Corp.'s Q1 2026 revenue and EPS?
- Briacell Therapeutics Corp. reported eps of $-2.58 for Q1 2026.
- Did Briacell Therapeutics Corp. beat estimates in Q1 2026?
- EPS beat the consensus estimate of $-4.84 by $2.26.
- How did Briacell Therapeutics Corp.'s Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 88.9% from $-23.30.
- Where can I find Briacell Therapeutics Corp.'s Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001493152-26-009382) and the 10-Q periodic report (0001493152-26-009557) directly on SEC EDGAR. The filing index links above go to sec.gov.
